StockVS

TSX · CAD · ETF

Middlefield Healthcare Dividend ETF (MHCD.TO) ETF Analysis

MHCD.TO
Expense ratio 1.23% Yield 3.69% Assets CA$159.55M Since July 21, 2017 Family Middlefield Limited

Last Updated: October 21, 2026

CA$12.68
−CA$0.05 (−0.43%)

October 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MHCD.TO with… →

MHCD.TO Annualized Returns

PeriodAnnualizedCA$100 becomes
1 year+15.25%CA$115.25
3 years+11.95%CA$140.32
5 years+7.65%CA$144.56
Since July 21, 2017+8.60%CA$214.54

Returns are total returns computed from daily closes, with dividends reinvested. As of October 21, 2026.

MHCD.TO Return by Calendar Year

2017 and 2026 are partial years

View as table ↓View as chart ↑
YearReturn
2026 (partial year)+10.93%
2025+8.97%
2024+12.72%
2023+0.83%
2022−2.50%
2021+16.25%
2020+10.48%
2019+12.48%
2018+7.46%
2017 (partial year)+3.18%

MHCD.TO Monthly Returns

−10%+9%
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026−0.4+3.4−5.9−2.9+2.5+7.9+0.8+3.8−0.8+2.7——
2025+7.1+1.7−3.1−5.9−3.1+0.3−1.8+3.5+1.9+4.4+8.0−3.3
2024+4.9+2.8+3.0−2.1+1.7+2.6+1.4+3.3−1.5−1.7+2.0−3.8
2023−2.2−1.4+0.9+3.7−2.4+1.0−0.2+2.7−3.5−2.2+2.6+2.1
2022−8.6−1.3+0.9+0.7−2.3+0.5+4.5−4.4+1.6+6.0+2.7−2.0
2021+3.8−4.7−1.7+1.2−2.1+7.7+3.8+4.3−2.1−2.8+2.7+6.0
2020+3.7−6.0−3.1+8.9+1.0−1.2+5.6−1.2+1.3−6.5+6.8+1.8
2019+4.3+2.1+1.5−3.2−2.4+2.4+1.8+0.1−2.3+2.9+5.7−0.7
2018+4.8−2.0−0.9+0.8+6.4+3.5+0.0+6.2−0.0−9.7+5.6−6.0
2017———————+2.4+2.2+0.8+2.2−3.0

Monthly total returns with dividends reinvested; each cell prints its signed value.

MHCD.TO Volatility & Risk

Volatility: 9 yrs · Beta: 3 yrs
Annualized volatility
16.20%
Beta (3y)
1.01
Best year
+16.25%

2021

Worst year
−2.50%

2022

Volatility is the annualized standard deviation of daily returns. As of October 21, 2026.

Top Holdings

# Symbol Name Weight
1 LLY Eli Lilly and Co 7.31%
2 JNJ Johnson & Johnson 6.6%
3 ABBV AbbVie Inc 5.35%
4 MRK Merck & Co Inc 5.17%
5 TMO Thermo Fisher Scientific Inc 4.99%
6 AZN.L AstraZeneca PLC 3.41%
7 DHR Danaher Corp 3.11%
8 ABT Abbott Laboratories 3.03%
9 NTRA Natera Inc 2.94%
10 MDT Medtronic PLC 2.53%

Analysis

Data-derived

Fund Overview

Middlefield Healthcare Dividend ETF (MHCD.TO) is an exchange-traded fund. Total net assets stand at CA$159.55M. Annual costs run at an expense ratio of 1.23%. On a CA$10,000 position that is CA$123.00 a year. The fund is issued by Middlefield Limited. It has been trading since July 21, 2017.

The largest positions on file are Eli Lilly and Co (LLY), Johnson & Johnson (JNJ), and AbbVie Inc (ABBV). Eli Lilly and Co alone accounts for 7.31% of the portfolio. The ten largest positions together make up 44.45% of the fund.

Performance Analysis

MHCD.TO last closed at CA$12.68 on October 21, 2026. Over the trailing twelve months the total return is +15.25%. Across 5 years the annualized return works out at +7.65%. The trailing distribution yield is 3.69%.

So far in 2026 the total return is +10.93%. Across the complete calendar years on file, 2021 returned +16.25% and 2022 returned −2.50%. Of the 8 complete calendar years on file, 7 finished higher.

Price & Risk Profile

Daily returns over the trailing 9 years annualize to a volatility of 16.2%. The reported beta is 1.01. Over the past 52 weeks the price has ranged from CA$10.76 to CA$12.91. The latest close sits 17.8% above that 52-week low. The volatility figure is calculated from the stored daily closes, the same series the charts on this page use.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

More Middlefield Limited ETFs